The National Medical Products Administration (NMPA) has released the 56th batch of reference drugs for generic quality consistency evaluation (GQCE) work, including 14 injectables among a total of 74 new specifications.
Batch Details
The latest batch comprises 74 new drug specifications, with 14 being injectables. This marks the continued expansion of the GQCE program, which aims to ensure the quality and consistency of generic drugs in China.
Modifications
Two injectable specifications were modified due to changes in marketing authorization holders (MAHs). These adjustments reflect updates in regulatory requirements and market dynamics.-Fineline Info & Tech
